Press Releases from DelveInsight Business Research (6359 total)
Libmeldy Sales Market Forecast Signals Transformational Shift in Rare Disease Th …
The global rare disease treatment landscape is undergoing a profound transformation, and at the forefront of this evolution is Libmeldy (atidarsagene autotemcel), a groundbreaking gene…
Burosumab Sales Forecast Signals Robust Market Expansion Through 2034, Driven by …
The global Burosumab Sales Market Forecast is poised for significant growth through 2034, fueled by strong clinical adoption, expanding therapeutic indications, and increasing awareness of…
Casimersen Market Set for Sustainable Growth Through 2034 Driven by Precision Ge …
The Duchenne muscular dystrophy (DMD) treatment landscape continues to evolve with significant advancements in precision medicine, and Casimersen (Amondys 45) is emerging as a key…
Cerliponase Alfa Market Set for Transformational Growth Through 2034, Driven by …
The global market for Cerliponase alfa, commercially known as BRINEURA and developed by BioMarin Pharmaceutical, is poised for substantial revenue expansion through 2034. According to…
Chronic Spontaneous Urticaria Market: Rapid Increment Driven by Innovation by 20 …
DelveInsight's report, "Chronic Spontaneous Urticaria Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Chronic Spontaneous Urticaria landscape. The report delivers detailed…
Chlamydia Infections Pipeline 2026: Therapies Under Investigation, Clinical Tria …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Chlamydia Infections pipeline constitutes 5+ key companies continuously working towards developing 5+ Chlamydia Infections…
Metastatic HER2-positive Breast Cancer Market: High-Growth Opportunities for Inv …
DelveInsight's "Metastatic HER2-positive Breast Cancer Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Metastatic HER2-positive Breast Cancer, historical and forecasted…
Obsessive Compulsive Disorder Market: Accelerating Growth and Pipeline Impact by …
DelveInsight's "Obsessive Compulsive Disorder Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Obsessive Compulsive Disorder, historical and forecasted epidemiology as…
Huntington's Disease Market: Strong Pharma Growth Forecast Through 2034 - DelveI …
DelveInsight's "Huntington's Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Huntington's Disease, historical and forecasted epidemiology as well as…
Benign Prostatic Hyperplasia Pipeline 2026: Latest FDA Approvals, Clinical Trial …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Benign Prostatic Hyperplasia pipeline constitutes 10+ key companies continuously working towards developing 10+ Benign…
Intrahepatic Cholangiocarcinoma Pipeline 2026: Key Developments, Emerging Therap …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, Intrahepatic Cholangiocarcinoma pipeline constitutes 18+ key companies continuously working towards developing 20+ Intrahepatic Cholangiocarcinoma…
Acquired Hemophilia A Pipeline 2026: FDA Approvals and Clinical Trials Landscape …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Acquired Hemophilia A pipeline constitutes 10+ key companies continuously working towards developing 10+ Acquired…
Coccidioidomycosis Pipeline 2026: Therapies, MOA Insights, and Key Clinical Tria …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Coccidioidomycosis pipeline constitutes 3+ key companies continuously working towards developing 3+ Coccidioidomycosis treatment therapies,…
Cognitive Impairment Associated with Schizophrenia Pipeline 2026: MOA, ROA, FDA- …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Cognitive Impairment Associated with Schizophrenia pipeline constitutes 3+ key companies continuously working towards developing…
Single Ventricle Heart Disease Market: Rapid Increment Driven by Innovation by 2 …
DelveInsight's "Single Ventricle Heart Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Single Ventricle Heart Disease, historical and forecasted…
Anemia In Chronic Kidney Disease Pipeline 2026: FDA Updates, Therapy Innovations …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Anemia In Chronic Kidney Disease pipeline constitutes 10+ key companies continuously working towards developing…
ALK-positive NSCLC Pipeline 2026: Key Companies, MOA, ROA, and Clinical Trials E …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, ALK-positive NSCLC pipeline constitutes 6+ key companies continuously working towards developing 7+ ALK-positive NSCLC…
Age Related Vision Dysfunction Market: High-Growth Opportunities for Investors t …
DelveInsight's "Age Related Vision Dysfunction Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Age Related Vision Dysfunction, historical and forecasted…
Adult-Onset Growth Hormone Deficiency Pipeline 2026: Latest FDA Approvals, Clini …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Adult-Onset Growth Hormone Deficiency pipeline constitutes 3+ key companies continuously working towards developing 3+…
Atherosclerotic Cardiovascular Disease Market: Expanding Revenue Landscape to 20 …
DelveInsight's "Atherosclerotic Cardiovascular Disease (ASCVD) Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Atherosclerotic Cardiovascular Disease, historical and forecasted epidemiology…
Achondroplasia Market: Rapid Increment Driven by Innovation by 2034 - DelveInsig …
DelveInsight's "Achondroplasia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Achondroplasia, historical and forecasted epidemiology as well as the Achondroplasia…
Sjogren's Syndrome Market: High-Growth Opportunities for Investors to 2034 - Del …
DelveInsight's report "Sjogren's Syndrome Market Insights, Epidemiology, and Market Forecast-2034," provides a comprehensive analysis of the Sjogren's Syndrome landscape. The report delivers detailed insights into…
Bayer and Regeneron "EYLEA" Market size expansion of Several Folds by 2034
[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on EYLEA (Bayer and Regeneron) providing insights…
Spark Therapeutics "LUXTURNA" Market size expansion of Several Folds by 2034
[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on LUXTURNA (Spark Therapeutics) providing insights into…
Murine Double Minute 2 (MDM2) Inhibitor Pipeline 2026: Therapies Under Investiga …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Murine Double Minute 2 (MDM2) Inhibitor pipeline constitutes key companies continuously working towards developing…
Mucopolysaccharidosis Type I Pipeline 2026: MOA and ROA Insights, Clinical Trial …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Mucopolysaccharidosis Type I pipeline constitutes 8+ key companies continuously working towards developing 8+ Mucopolysaccharidosis…
Lyme Disease Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Lyme Disease pipeline constitutes 7+ key companies continuously working towards developing 7+ Lyme Disease…
Marginal Zone Lymphoma Pipeline 2026: FDA Updates, Therapy Innovations, and Clin …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Marginal Zone Lymphoma pipeline constitutes 50+ key companies continuously working towards developing 50+ Marginal…
Dementia With Diabetes Market: Accelerating Growth and Pipeline Impact by 2034 - …
DelveInsight's "Dementia With Diabetes Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Dementia With Diabetes, historical and forecasted epidemiology as…
Burns Pipeline 2026: Key Companies, MOA, ROA, and Clinical Trials Evaluation by …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Burns pipeline constitutes 12+ key companies continuously working towards developing 12+ Burns treatment therapies,…
NAFLD Therapeutic Pipeline Reaches New Heights with 90+ Companies Advancing Over …
DelveInsight, a prominent healthcare consulting and market intelligence firm specializing in life sciences, has announced the launch of its latest report, "Non-Alcoholic Fatty Liver Disease…
KYNMOBI Sales Outlook 2032: Sublingual Apomorphine Therapy Reshaping Parkinson's …
The evolving treatment landscape for Parkinson's disease is witnessing a significant transformation with the growing adoption of innovative therapies such as KYNMOBI.
According to DelveInsight's…
JNJ-1887 Market Forecast 2034: Next-Generation Immunology & Gene Therapy Innovat …
DelveInsight's latest report, "JNJ-1887 Sales Forecast and Market Size Analysis - 2034," highlights the significant commercial potential of JNJ-1887, an emerging next-generation therapy developed by…
Prader-Willi Syndrome Market: High-Growth Opportunities for Investors to 2034 - …
DelveInsight's "Prader-Willi Syndrome Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Prader-Willi Syndrome, historical and forecasted epidemiology as well as…
Spinocerebellar Ataxia Market: Accelerating Growth and Pipeline Impact by 2034- …
DelveInsight's "Spinocerebellar Ataxia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Spinocerebellar Ataxia, historical and forecasted epidemiology as well as…
Myotonic Dystrophy Market: Strong Pharma Growth Forecast Through 2034 - DelveIns …
DelveInsight's "Myotonic Dystrophy Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myotonic Dystrophy, historical and forecasted epidemiology as well as…
Down Syndrome Pipeline 2026: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Pr …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Down Syndrome pipeline constitutes 5+ key companies continuously working towards developing 5+ Down Syndrome…
Acute Respiratory Distress Syndrome Pipeline 2026: Therapies Under Investigation …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Acute Respiratory Distress Syndrome pipeline constitutes 50+ key companies continuously working towards developing 50+…
Developmental and Epileptic Encephalopathy Market: Strong Pharma Growth Forecast …
DelveInsight's "Developmental and Epileptic Encephalopathy Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Developmental and Epileptic Encephalopathy, historical and forecasted…
Chronic Kidney Disease Market: High-Growth Opportunities for Investors to 2034 - …
The Chronic Kidney Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage…
Polymyositis Market: Rapid Increment Driven by Innovation by 2034 - DelveInsight
DelveInsight's "Polymyositis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Polymyositis, historical and forecasted epidemiology as well as the Polymyositis…
Acute Myocardial Infarction Market: Accelerating Growth and Pipeline Impact - De …
DelveInsight's report "Acute Myocardial Infarction Market Insights, Epidemiology, and Market Forecast-2034", provides a comprehensive analysis of the Acute Myocardial Infarction landscape. The report delivers…
High-Grade Glioma Pipeline 2026: MOA, ROA, FDA-Approved Drugs, and Clinical Tria …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, High-Grade Glioma pipeline constitutes 150+ key companies continuously working towards developing 150+ High-Grade Glioma…
Head and Neck Squamous Cell Carcinomas Market: High-Growth Opportunities for Inv …
DelveInsight's "Head and Neck Squamous Cell Carcinomas Patient Pool Analysis, Market Size and Market Forecast APAC - 2034′′ report offers an in-depth understanding of the…
Biliary Tract Cancer Pipeline 2026: Key Developments, Emerging Therapies, and Cl …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Biliary Tract Cancer pipeline constitutes 80+ key companies continuously working towards developing 80+ Biliary…
IC-MPGN Market: Expanding Revenue Landscape to 2034 - DelveInsight
DelveInsight's "Immune Complex Membranoproliferative Glomerulonephritis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Immune Complex Membranoproliferative Glomerulonephritis, historical and forecasted…
Giant Cell Arteritis Market: Growth Momentum Across 7MM to 2034 - DelveInsight
The Giant Cell Arteritis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage…
Hereditary Angioedema Market to Surpass USD 3 Billion by 2034 Across 7MM | 10+ C …
DelveInsight's "Hereditary Angioedema Market Insights, Epidemiology, and Market Forecast 2034" report delivers an in-depth understanding of the Hereditary Angioedema, historical and forecasted epidemiology as well…
Roche "Cendakimab" Market size expansion of Several Folds by 2034
[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on Cendakimab (Roche) providing insights into the…
Neuroendocrine Tumor Market: High-Growth Opportunities for Investors to 2034 - D …
The Neuroendocrine Tumor market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Neuroendocrine…
Go To Page: 1 2 3 4 5 6 7 8 9 10 61 62 63 64 65 66 67 68 69 70
